HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

KEQU

Kewaunee Scientific Corporation (NASDAQ)

Consumer Cyclical — Furnishings, Fixtures & Appliances

Kewaunee Scientific Corporation, together with its subsidiaries, designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States and internationally. It operates through two segments, Lab Products Group (LPG) and International. The company offers steel and wood casework and laboratory cabinetry, fume hoods, adaptable modular and flexible systems, movable workstations, stand-alone and work benches, computer enclosures, biological safety cabinets, CO2 incubators, ultralow freezers, epoxy resin work surfaces and sinks, and other laboratory products. It also provides facility design, detailed engineering, construction, and project management services. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and healthcare markets; and its technical products are used in facilities manufacturing computers and light electronics, and by users of computer and networking furniture. It sells its products through dealers, its subsidiaries, and a national stocking distributor. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.

None
$36.57
+$1.05 (+2.96%)
Sign in to add KEQU to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$104.97M
P/E Ratio (TTM)11.36
Forward P/E16.93
EPS (TTM)$3.22
Dividend Yield-
Profit Margin3.41%
Revenue Growth-7.50%
ROE14.63%
Debt/Equity73.97
Recommendation None
Analyst Target-
Analysts-
Indexes NASDAQ

Technical Indicators

RSI (14)52.8
Beta0.69
SMA 20-
SMA 40-
52-Week High$60.89
52-Week Low$33.27
50-Day Avg$37.63
200-Day Avg$39.13
Avg Volume3.8K
Volume10.2K

Performance Analysis

NEUTRAL

KEQU presents a mixed picture with both positive and negative indicators.

~ Trading at 12% of its 52-week range.
~ RSI at 52.8 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
+ P/E of 11.4 suggests the stock may be undervalued.
- Revenue declined 7.5% year-over-year.
~ Wall Street consensus is "none".

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:16 UTC

Back to Screener Export Report